2Firsts Successfully Held US NGPs Regulation Policy and Compliance Development Workshop: Elevating International Compliance Exchange and Collaboration

2Firsts Events by 2FIRSTS, edited by Sophia Lyu
Aug.29.2024
2Firsts Successfully Held US NGPs Regulation Policy and Compliance Development Workshop: Elevating International Compliance Exchange and Collaboration
2Firsts successfully hosted the "US NGPs Regulation Policy and Compliance Development Workshop" in Shenzhen, China on August 26, 2024.

On August 26, 2024, the "US NGPs Regulation Policy and Compliance Development Workshop" organized by 2Firsts was successfully held in Shenzhen, China. The conference invited compliance policy experts from the United States and representatives from leading e-cigarette companies in China to participate. Attendees engaged in in-depth discussions on the latest trends and challenges in regulatory policies in the world's largest e-cigarette market, the U.S. market.

 

American Experts Explain the Latest FDA Requirements

 

This seminar featured several high-level experts from American compliance companies Accorto and Iner Scientific. Accorto's CEO Tom Beaudet and CSO Dr. Vincent Angelico, as well as Inter Scientific's Executive Director David Lawson and Chief Scientist Chris Corbett, delivered speeches during the event.

 

American experts first provided a detailed overview of the latest policy changes by the FDA regarding the review of flavored e-cigarette products, delving into core areas of scientific review such as toxicology and cancer risk assessment. They then conducted a comprehensive analysis of the standardized operational procedures and necessary review processes for the marketing of tobacco products. For example, when evaluating a product, the FDA considers the potential negative impact on public health (such as harm to minors) and potential positive impacts (such as helping adult smokers quit).

 

American experts have also made several suggestions for the compliant development of Chinese e-cigarette companies in the United States. For example, Chinese companies should strengthen the importance of using data to prove the compliance of their products. For instance, in terms of flavors, companies should use data to demonstrate that their products are beneficial for legal smokers and do not attract minors.

 

Finally, American experts emphasize that from now until January next year, it is a crucial phase for companies to comply with regulations in the US market. It is expected that regulatory policies will officially take effect in January 2025 and impact the market landscape.

 

2Firsts Successfully Held US NGPs Regulation Policy and Compliance Development Workshop: Elevating International Compliance Exchange and Collaboration
Co-founders of 2Firsts, Alan Zhao and Echo Guo, took a photo with international compliance experts. From left to right: Co-founder and CEO of 2Firsts, Alan Zhao; Co-founder and COO of 2Firsts, Echo Guo; Accorto's CSO Dr. Vincent Angelico; Inter Scientific's Executive Director David Lawson; Accorto's CEO Tom Beaudet | 2Firsts

 

Chinese Top Companies Share Actions and Challenges in Complying with US Regulations

 

The meeting invited several top Chinese e-cigarette companies to participate, all of which are important players in the current U.S. market. Representatives from these companies briefed on their progress in regulatory compliance in the U.S. market. Overall, it can be seen from the speeches of these representatives that top Chinese e-cigarette companies are taking U.S. regulatory requirements very seriously and have invested significant resources in the corresponding PMTA applications.

 

During the meeting, representatives engaged in in-depth discussions with international compliance experts on issues related to the United States' new tobacco regulatory policies. Business representatives pointed out that a major challenge they currently face is the lack of clarity in certain US regulatory policies, which makes it difficult for companies to determine the direction and intensity of their compliance efforts in the US market. They suggested that all parties should work together to further enhance communication between US market regulators and businesses, promote dialogue on regulatory policies, and help companies effectively carry out compliance efforts.

 

International experts engaged in lively discussions with representatives from Chinese companies, providing detailed answers to their questions. The experts commended the attending companies for their in-depth research and long-term commitment to compliance. They also expressed understanding for the challenges Chinese companies face in complying with regulations in the U.S. market, and assured that they will make every effort to facilitate improvements in these areas.

 

2Firsts will Continue to Support International Compliance Communication and Collaboration

 

At this meeting, representatives from various companies shared their experiences and challenges in compliance in the United States. The feedback from companies indicates that Chinese companies face significant industry-wide difficulties and challenges in compliance in international markets, including the US. Particularly, there is a pressing need for clearer understanding and anticipation of overseas market regulatory policies. Solving these issues cannot be achieved solely through the efforts of individual companies, requiring collective attention and efforts at the industry level.

 

As a leading global vaping industry media and consultancy, 2Firsts is dedicated to supporting Chinese companies in achieving high-level internationalization and expediting the compliance of global markets through professional media coverage and in-depth research, in order to contribute to the high-quality development of the global aerosol industry. In the field of policy research and compliance development, 2Firsts has conducted continuous research and investment. In July 2024, 2Firsts released the "2024 Global Novel Tobacco Regulation Report" in Chinese and English to the world, marking the first systematic annual review and analysis of global policies in the industry.

 

2Firsts Successfully Held US NGPs Regulation Policy and Compliance Development Workshop: Elevating International Compliance Exchange and Collaboration
2024 Global Vape Regulation Report" produced by 2Firsts (English version) | Image source: 2Firsts

 

The convening of the "US NGPs Regulation Policy and Compliance Development Workshop" represents another exploration by 2Firsts in the field of international compliance exchange and collaboration. Experts and corporate representatives from China and abroad have fully recognized the significance and value of this seminar, and expressed gratitude to 2Firsts for their contributions to the event.

 

At the end of the meeting, Alan Zhao, co-founder and CEO of 2FIRSTS, said at the meeting: "2Firsts will carefully summarize the speeches and suggestions of the experts and business representatives present at the meeting, fully leverage 2Firsts' international influence in the media and research fields and the platform value at the industry level, to contribute to the compliance development of enterprises."

 

2Firsts will continue to hold global market policy seminars, welcoming experts and business representatives from both domestic and international participants. For more information, contact: info@2firsts.com, or scan the QR code.

 

2Firsts Successfully Held US NGPs Regulation Policy and Compliance Development Workshop: Elevating International Compliance Exchange and Collaboration

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
A new Swedish study found oral mucosal lesions in 79% of examined nicotine pouch users and 89% of tobacco-derived snus users, with different tissue-response patterns between the two categories. For manufacturers and regulators, the findings shift attention toward product formulation, flavouring, pouch materials and local oral exposure, not only whether a product contains tobacco. The study found no higher prevalence of caries or periodontal disease, but it could not establish causality, long-term outcomes or differences between individual products or designs.
Special Report
Jul.27
IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
Philip Morris International’s IQOS has entered the Kantar BrandZ Top 100 Most Valuable Global Brands for the first time, ranking No. 74 with a brand value of $36.634 billion and becoming one of only three newcomers to the 2026 ranking. Kantar said the combined value of the Global Top 100 reached $13.1 trillion, up 22% year on year, while the threshold for entry rose to a record high. PMI says IQOS has more than 35 million users worldwide and surpassed $10 billion in annual net revenues within a decade of launch.
Sep.03
UK Proposes Stricter Vape Packaging Rules as Retailers Warn of £330 Million Impact
UK Proposes Stricter Vape Packaging Rules as Retailers Warn of £330 Million Impact
The UK government has launched a nationwide consultation on vape packaging, appearance and retail displays, proposing tighter rules to reduce youth appeal while industry groups warn of significant compliance costs.
Innovation
Jul.20
Product | PMI Japan Expands ZYN by IQOS Strength Portfolio With Strong Series, Increasing Lineup to 12 Products
Product | PMI Japan Expands ZYN by IQOS Strength Portfolio With Strong Series, Increasing Lineup to 12 Products
Philip Morris Japan (PMJ) has expanded the ZYN by IQOS oral tobacco pouch portfolio in Japan with four new ZYN Strong products, adding a third intensity level alongside the existing Low and Medium ranges. The Strong series first entered selected duty-free channels in Japan on July 1, 2026, before expanding to IQOS stores, the ZYN Online Store and selected tobacco retailers from August 18. The expansion increases the Japanese ZYN by IQOS lineup from eight to 12 products.
Aug.20
Smoore Wins Three Heated Device Supply Lots in China Tobacco Jiangsu’s Overseas Market Project Covering Japan, South Korea and Southeast Asia
Smoore Wins Three Heated Device Supply Lots in China Tobacco Jiangsu’s Overseas Market Project Covering Japan, South Korea and Southeast Asia
China Tobacco Jiangsu Industrial Co., Ltd. (JSIC) has completed its 2026-2028 heated device procurement project, with Shenzhen Smoore Technology Limited securing final supply contracts for three lots: U1, C1 and C2. The project was launched through a public tender in June 2026 to support overseas markets and involved heated tobacco devices carrying JSIC’s “iRod” trademark. Candidate supplier results published on July 13 showed Smoore ranked first for the three awarded lots, while Shenzhen Yunxi Intelligent Technology Co., Ltd. and Shenzhen Bodi Technology Development Co., Ltd. participated in the bidding process.
Aug.03
Nasdaq-Listed Vape Company iSpire Technology Restructures Leadership as Tuanfang Liu Becomes Sole CEO, BTIG Initiates Coverage on ODM Growth Opportunity
Nasdaq-Listed Vape Company iSpire Technology Restructures Leadership as Tuanfang Liu Becomes Sole CEO, BTIG Initiates Coverage on ODM Growth Opportunity
Nasdaq-listed vape company iSpire Technology has restructured its leadership team, with Tuanfang Liu becoming the company’s sole chief executive officer (CEO) and Michael Wang appointed CEO of Aspire North America. The move ends iSpire’s previous co-CEO structure and creates clearer responsibilities between group strategy and regional execution. Separately, BTIG initiated coverage on iSpire Technology with a Buy rating and a $3.50 price target, identifying ODM growth opportunities as a key investment factor.
Jul.27